How It’s Med
How It’s Med
Aug 5, 2022
Med Tech Talks Ep.62: Dr. Amol Deshpande Pt.2
Play • 31 min
💵$308 billion yearly - yet not all Canadians 🇨🇦 can get the healthcare they need or expect. Can Canadian innovation backed by VCs such help solve this? 🤔  

What does MD, Senior Director of the Health-Tech Ecosystem at @Mars Discovery District, host of the @Reboot Health Podcast, and co-chair of HaloHealth @Dr. Amol Deshpande think about this? Moreover, how would he explain VC to you - if you didn’t know what venture capital was? Tune in this time for our episode with Dr. Amol Deshpande to find out!



1:42 - 4:30 - What is due diligence? Amol relates how in his eyes, due diligence is an assessment of the probability that a startup will make it to the other end.

5:25 - 12:35 - What is the goal of HaloHealth, AiOT and other similar physician-driven innovation communities? Amol relates the power of a diverse community of physicians which can serve companies and VCs with feedback to provide product validation.

12:55 - 15:40 - What are the pain points of being an early-stage investor? As an angel, Amol believes that angel investing is tough but rewarding given the opportunity to support great founders.

16:03 - 18:49 - What tribulations do angels face when interacting with investors? Amol provides insight into the biases and perspectives that angels bring to conversations with startups.

19:00 - 21:25 - What separates and exponential startup from a non-exponential startup? Amol lays out what he means by those terms, and what the facets by which he evaluates potentially exponential companies.

21:40 - 25:20 - Why Reboot Health? Why Podcast? Amol lays out his rationale for starting his health tech podcast.

25:40 - 29:44 - What is the MaRS Innovation District, and what does Amol do as the Health Tech Ecosystem Senior Director? Amol gives us a deep dive of his behind-the-scenes work to support healthtech startups and the healthtech ecosystem.

More episodes
Clear search
Close search
Google apps
Main menu